IHS Chemical Week

World News and Views :: Top of the News

Covidien completes separation of pharmaceuticals business including its API business

1:05 AM MDT | July 2, 2013 | Deepti Ramesh

Healthcare products company Covidien (Dublin) says it has completed the previously announced separation of its pharmaceuticals business, which is now held by Mallinckrodt (Dublin), a new independent company. Covidien announced in December 2011 that it planned to spin-off the pharmaceuticals business, and the spin off includes the company’s active pharmaceutical ingredients (API) business. In the fiscal year ended 28 September 2012, the pharmaceuticals business of Covidien recorded sales of $2 billion, and the API business within that recorded sales of $433...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa